Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.540
-0.020 (-1.28%)
At close: May 23, 2025, 4:00 PM
1.550
+0.010 (0.66%)
After-hours: May 23, 2025, 4:24 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $34.47 million as of May 23, 2025. Its market cap has decreased by -84.34% in one year.
Market Cap
34.47M
Enterprise Value
-55.21M
1-Year Change
-84.34%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $34.47M, a decrease of -90.31%. That is a compound annual growth rate of -86.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 34.47M | -46.69% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 663.68B |
| Johnson & Johnson | 370.68B |
| AbbVie | 324.45B |
| Novo Nordisk | 305.65B |
| UnitedHealth Group | 278.79B |
| Abbott Laboratories | 234.04B |
| Novartis AG | 219.90B |
| AstraZeneca | 215.95B |